Matsushige, Japan

Goro Miyakoda

This inventor holds 4 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2001-2013.


% Patents Active = 50.0

Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Itano-gun, JP (2001)
  • Tokushima, JP (2003 - 2013)
  • Matsushige, JP (2013)

Company Filing History:


Years Active: 2001-2013

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Goro Miyakoda: Innovator in Pharmaceutical Composition

Introduction

Goro Miyakoda is a notable inventor based in Matsushige, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of angiogenesis and cytokine production.

Latest Patents

Miyakoda holds 4 patents, with his latest inventions focusing on innovative pharmaceutical compositions. One of his key patents is a pharmaceutical composition for promoting angiogenesis. This invention provides a solution that promotes angiogenesis even in a vascular culturing system without the effects of microcirculation. The composition includes at least one compound from a specific group of piperidine compounds. Another significant patent is an agent for inhibiting cytokine production and cell adhesion. This agent comprises compounds from thiazole derivatives, which are designed to inhibit cytokine production effectively.

Career Highlights

Goro Miyakoda is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address critical health issues.

Collaborations

Miyakoda has collaborated with esteemed colleagues such as Toyoki Mori and Masatoshi Chihiro, contributing to the advancement of pharmaceutical sciences.

Conclusion

Goro Miyakoda's contributions to pharmaceutical innovations highlight his role as a leading inventor in the field. His patents reflect a commitment to improving health outcomes through scientific research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…